JP2017525675A - 回旋筋腱板異常の処置 - Google Patents

回旋筋腱板異常の処置 Download PDF

Info

Publication number
JP2017525675A
JP2017525675A JP2017500883A JP2017500883A JP2017525675A JP 2017525675 A JP2017525675 A JP 2017525675A JP 2017500883 A JP2017500883 A JP 2017500883A JP 2017500883 A JP2017500883 A JP 2017500883A JP 2017525675 A JP2017525675 A JP 2017525675A
Authority
JP
Japan
Prior art keywords
rotator cuff
tendon
polypeptide
bmp
anomaly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017500883A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017525675A5 (enExample
Inventor
スコット エム． リースター
スコット エム． リースター
ジョン ダブリュ． スパーリング
ジョン ダブリュ． スパーリング
ヴァイネン アンドレ ジェイ． ファン
ヴァイネン アンドレ ジェイ． ファン
Original Assignee
メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ filed Critical メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ
Publication of JP2017525675A publication Critical patent/JP2017525675A/ja
Publication of JP2017525675A5 publication Critical patent/JP2017525675A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2017500883A 2014-07-09 2015-07-09 回旋筋腱板異常の処置 Pending JP2017525675A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462022516P 2014-07-09 2014-07-09
US62/022,516 2014-07-09
PCT/US2015/039743 WO2016007742A1 (en) 2014-07-09 2015-07-09 Treating rotator cuff conditions

Publications (2)

Publication Number Publication Date
JP2017525675A true JP2017525675A (ja) 2017-09-07
JP2017525675A5 JP2017525675A5 (enExample) 2018-07-19

Family

ID=55064896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500883A Pending JP2017525675A (ja) 2014-07-09 2015-07-09 回旋筋腱板異常の処置

Country Status (4)

Country Link
US (2) US10610570B2 (enExample)
EP (1) EP3166624B1 (enExample)
JP (1) JP2017525675A (enExample)
WO (1) WO2016007742A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023501925A (ja) * 2019-10-24 2023-01-20 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ 筋線維断片を利用した回旋腱板療法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3322481A4 (en) 2015-07-16 2019-03-06 Mayo Foundation for Medical Education and Research TREATMENT OF ROTATOR COIL DRESSES
US12310928B2 (en) 2020-11-16 2025-05-27 University Of Utah Research Foundation Enthesis healing
WO2024015257A1 (en) * 2022-07-15 2024-01-18 Mayo Foundation For Medical Education And Research Methods and materials for promoting bone growth

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009542681A (ja) * 2006-06-30 2009-12-03 バイオミメティック セラピューティクス， インコーポレイテッド 回旋筋腱板傷害を処置するためのｐｄｇｆ−生体マトリックス組成物および方法
JP2012126720A (ja) * 2010-11-26 2012-07-05 Chiba Univ コラーゲンの産生促進剤、プロテオグリカン産出促進剤及び軟骨細胞の遊走促進剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US5939388A (en) * 1986-07-01 1999-08-17 Rosen; Vicki A. Methods of administering BMP-5 compositions
EP0438803B1 (en) 1990-01-26 1997-03-12 Immunomedics, Inc. Vaccines against cancer and infectious diseases
HU222664B1 (hu) * 1995-06-05 2003-09-29 Genetics Institute, Llc Csont morfogenetikus protein (BMP) alkalmazása csont és ín vagy szalag funkcionális összeköttetésének regenerálására
CN1685055A (zh) 2001-10-31 2005-10-19 爱尔康公司 骨形态发生蛋白(bmp)、bmp受体和bmp结合蛋白及它们在诊断和治疗青光眼中的用途
US20040161481A1 (en) 2002-12-18 2004-08-19 Algorx Administration of capsaicinoids
ES2522575T3 (es) 2003-10-22 2014-11-17 Encelle, Inc. Composiciones de hidrogel bioactivo para la regeneración del tejido conjuntivo
US20100150885A1 (en) * 2005-06-01 2010-06-17 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
US8753391B2 (en) 2007-02-12 2014-06-17 The Trustees Of Columbia University In The City Of New York Fully synthetic implantable multi-phased scaffold
US9161903B2 (en) * 2008-10-31 2015-10-20 Warsaw Orthopedic, Inc. Flowable composition that hardens on delivery to a target tissue site beneath the skin
GB0908174D0 (en) 2009-05-13 2009-06-24 Isis Innovation Steroid containing composition and uses thereof
CA2847527A1 (en) * 2011-09-02 2013-03-07 Lifenet Health Bmp peptides & methods of use
EP3322481A4 (en) 2015-07-16 2019-03-06 Mayo Foundation for Medical Education and Research TREATMENT OF ROTATOR COIL DRESSES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009542681A (ja) * 2006-06-30 2009-12-03 バイオミメティック セラピューティクス， インコーポレイテッド 回旋筋腱板傷害を処置するためのｐｄｇｆ−生体マトリックス組成物および方法
JP2012126720A (ja) * 2010-11-26 2012-07-05 Chiba Univ コラーゲンの産生促進剤、プロテオグリカン産出促進剤及び軟骨細胞の遊走促進剤

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHAUDHURY S, CARR AJ: "Lessons we can learn from gene expression patterns in rotator cuff tears and tendinopathies", JOURNAL OF SHOULDER AND ELBOW SURGERY, vol. 21, no. 2, JPN6019015224, 2012, pages 191 - 199, ISSN: 0004026040 *
DEAN BJ, FRANKLIN SL, CARR AJ: "A systematic review of the histological and molecular changes in rotator cuff disease", BONE AND JOINT RESEARCH, vol. 1, no. 7, JPN6019015225, 2012, pages 158 - 166, ISSN: 0004026041 *
KOVACEVIC D, RODEO SA: "Biological augmentation of rotator cuff tendon repair", CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, vol. 466, no. 3, JPN6019015222, 2008, pages 622 - 633, ISSN: 0004026039 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023501925A (ja) * 2019-10-24 2023-01-20 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ 筋線維断片を利用した回旋腱板療法

Also Published As

Publication number Publication date
EP3166624A4 (en) 2018-06-27
US20170128534A1 (en) 2017-05-11
EP3166624A1 (en) 2017-05-17
EP3166624B1 (en) 2020-06-03
US10610570B2 (en) 2020-04-07
US20200397864A1 (en) 2020-12-24
WO2016007742A1 (en) 2016-01-14

Similar Documents

Publication Publication Date Title
CN102712695B (zh) 能够诱导细胞死亡的ror1生物抑制剂
US20200157237A1 (en) Lymphocyte antigen cd5like (cd5l) monomer, homodimer, and interleukin 12b (p40) heterodimer antagonists and methods of use thereof
JP6276818B2 (ja) 特に移植片対宿主病（ＧｖＨＤ）を予防するための抗ＣＤ４抗体
US20200397864A1 (en) Treating rotator cuff conditions
RU2662933C2 (ru) Антитела против cd26 и их применение
US20180163178A1 (en) Auf1 encoding compositions for muscle cell uptake, satellite cell populations, and satellite cell mediated muscle generation
US20140079637A1 (en) Methods and compositions for improving antiangiogenic therapy with anti-integrins
Deveza et al. Polymer-DNA nanoparticle-induced CXCR4 overexpression improves stem cell engraftment and tissue regeneration in a mouse hindlimb ischemia model
JP4555089B2 (ja) ｉｎｖｉｔｒｏ免疫感作により創製されたハイブリドーマからの抗体の高生産量の生成方法
US20140141020A1 (en) Anti-cd3 therapies
US20190033306A1 (en) Recurrent fusion genes in human cancers
Yao et al. Expression of sclerostin scFv and the effect of sclerostin scFv on healing of osteoporotic femur fracture in rats
CN102333543B (zh) 细胞粘附抑制剂及其用途
US20210139601A1 (en) Lymphocyte antigen cd5-like (cd5l) monomer, homodimer, and interleukin 12b (p40) heterodimer agonists and methods of use thereof
IL296755A (en) Monoclonal antibodies targeting hsp70 and therapeutic uses thereof
WO2021015986A1 (en) Cancer vaccine compositions and methods for using same to prevent and/or treat cancer
WO2012157589A1 (ja) 細胞接着阻害剤、細胞増殖阻害剤、並びに癌の検査方法および検査用キット
US11426462B2 (en) Monovalent anti-CD3 adjuvants
JP2024515976A (ja) 骨格再生のための機能不全骨格幹細胞の生化学的活性化
US20130202586A1 (en) Stem cell therapy using inhibitors of lysophosphatidic acid
Humrich et al. 06.08 Low-dose il-2 therapy in refractory sle: results from a single centre phase i/iia clinical trial

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180608

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180608

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190508

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190806

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20191225